Leadership changes Recent C-suite appointments signal a strategic shift toward customer experience and growth. Target approach: engage with the new COO and CEO to discuss roadmap alignment, onboarding enhancements, and expansion of surgical scheduling capabilities to enterprise practices.

Growth potential Revenue size and headcount place Surgimate in a mid-market SaaS segment with room for upsell into larger surgical networks. Sales can position expanded modules for medical device coordination, patient access, and advanced analytics to support multi-site practices.

Market positioning Position as a comprehensive surgical workflow platform that improves reimbursement speed and block-time utilization. Prospect conversations can emphasize integration with EHRs, codes confirmation for expedited reimbursements, and streamlined communication across the practice.

Strategic partnerships Tech stack includes major cloud and outreach tools (Azure, OpenAI, GitHub, Salesloft) suggesting readiness for integrations and AI-driven optimizations. Propose joint pilots with complementary vendors in scheduling, billing, or device coordination to accelerate adoption.

Expansion opportunities Recent leadership hires in New York and orthopedics growth indicate targeted expansion in high-volume specialties and urban markets. Focus sales on multi-site surgical groups, specialty clinics, and hospital-adjacent practices seeking centralized coordination and improved reimbursement workflows.